Todd Lasco

1.8k total citations
53 papers, 1.4k citations indexed

About

Todd Lasco is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Todd Lasco has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 30 papers in Epidemiology and 10 papers in Clinical Biochemistry. Recurrent topics in Todd Lasco's work include Mycobacterium research and diagnosis (10 papers), Tuberculosis Research and Epidemiology (10 papers) and Bacterial Identification and Susceptibility Testing (10 papers). Todd Lasco is often cited by papers focused on Mycobacterium research and diagnosis (10 papers), Tuberculosis Research and Epidemiology (10 papers) and Bacterial Identification and Susceptibility Testing (10 papers). Todd Lasco collaborates with scholars based in United States, Austria and Japan. Todd Lasco's co-authors include Kevin W. Garey, David N. McMurray, Teizo Yoshimura, Nicholas D. Beyda, Mohammad Jahangir Alam, Dhara N. Shah, Ian M. Orme, Hannah R. Palmer, Shannon Sedberry Allen and Oliver C. Turner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Todd Lasco

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd Lasco United States 22 877 653 360 162 134 53 1.4k
Paula A. Revell United States 26 736 0.8× 648 1.0× 271 0.8× 359 2.2× 148 1.1× 52 1.9k
Cathy A. Petti United States 22 588 0.7× 946 1.4× 244 0.7× 256 1.6× 127 0.9× 59 1.7k
Manuel Rodríguez‐Iglesias Spain 20 374 0.4× 430 0.7× 190 0.5× 229 1.4× 48 0.4× 99 1.2k
Birgitta Henriques Normark Sweden 21 553 0.6× 1.2k 1.8× 396 1.1× 293 1.8× 97 0.7× 32 2.2k
Richard C. Huard United States 20 1.1k 1.3× 911 1.4× 157 0.4× 213 1.3× 459 3.4× 33 1.5k
Nobuyuki Shimono Japan 21 620 0.7× 736 1.1× 169 0.5× 380 2.3× 140 1.0× 97 1.8k
Tim Henkel United States 15 784 0.9× 506 0.8× 230 0.6× 179 1.1× 71 0.5× 29 1.4k
Issei Tokimatsu Japan 20 964 1.1× 694 1.1× 81 0.2× 177 1.1× 70 0.5× 101 1.7k
Maria Carla Liberto Italy 19 286 0.3× 452 0.7× 201 0.6× 253 1.6× 95 0.7× 79 1.2k
Ronald G. Washburn United States 20 1.6k 1.8× 1.1k 1.7× 196 0.5× 226 1.4× 114 0.9× 41 2.3k

Countries citing papers authored by Todd Lasco

Since Specialization
Citations

This map shows the geographic impact of Todd Lasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Lasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Lasco more than expected).

Fields of papers citing papers by Todd Lasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Lasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Lasco. The network helps show where Todd Lasco may publish in the future.

Co-authorship network of co-authors of Todd Lasco

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Lasco. A scholar is included among the top collaborators of Todd Lasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Lasco. Todd Lasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Lasco, Todd, et al.. (2024). Detection of invasive Bartonella infections with next-generation sequencing of microbial cell-free DNA. SHILAP Revista de lepidopterología. 4(1). e20–e20. 3 indexed citations
4.
Sohail, M. Rizwan, et al.. (2024). Clinical utility of plasma microbial cell-free DNA sequencing in determining microbiologic etiology of infectious syndromes in solid organ transplant recipients. Therapeutic Advances in Infectious Disease. 11. 2028543459–2028543459. 3 indexed citations
5.
Wang, Melinda, et al.. (2023). The impact of a blood-culture diagnostic stewardship intervention on utilization rates and antimicrobial stewardship. SHILAP Revista de lepidopterología. 3(S2). s60–s61. 1 indexed citations
6.
Zaki, Ahmed, Anne J Gonzales-Luna, Nicholas D. Beyda, Todd Lasco, & Kevin W. Garey. (2023). Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(6). 466–472.
7.
Herlihy, James, et al.. (2023). The impact of a blood-culture diagnostic stewardship intervention on utilization rates and antimicrobial stewardship. Infection Control and Hospital Epidemiology. 45(5). 670–673. 4 indexed citations
8.
9.
Franklin, Alex, et al.. (2023). Impact of gastrointestinal polymerase chain reaction panels on antibiotic utilization in hospitalized adult patients. SHILAP Revista de lepidopterología. 3(1). e135–e135. 1 indexed citations
10.
Mohajer, Mayar Al & Todd Lasco. (2023). The Impact of Initial Specimen Diversion Systems on Blood Culture Contamination. Open Forum Infectious Diseases. 10(5). ofad182–ofad182. 7 indexed citations
11.
Chen, Alice P., Kenny Smith, Paola Zucchi, et al.. (2017). Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline. Diagnostic Microbiology and Infectious Disease. 88(4). 365–367. 10 indexed citations
12.
Cottreau, Jessica, David Thompson, J. Nicholas O’Donnell, et al.. (2015). Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia. PLoS ONE. 10(11). e0143845–e0143845. 14 indexed citations
13.
Aitken, Samuel L, et al.. (2014). Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagnostic Microbiology and Infectious Disease. 81(1). 4–8. 27 indexed citations
14.
Beyda, Nicholas D., et al.. (2014). FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia. Clinical Infectious Diseases. 59(6). 819–825. 143 indexed citations
15.
McGrath, Danielle M., E. Magda Barbu, Wouter H. P. Driessen, et al.. (2013). Mechanism of action and initial evaluation of a membrane active all- D -enantiomer antimicrobial peptidomimetic. Proceedings of the National Academy of Sciences. 110(9). 3477–3482. 46 indexed citations
16.
Hirsch, Elizabeth B., Kai‐Tai Chang, Paola Zucchi, et al.. (2013). An evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae. Journal of Infection and Chemotherapy. 20(3). 224–227. 10 indexed citations
17.
Lasco, Todd, Mercedes Gonzalez‐Juarrero, Armin Saalmüller, & Joan K. Lunney. (2007). Cross-reaction of anti-human CD monoclonal antibodies on guinea pig cells: A summary of the guinea pig section of the HLDA8 animal homologues data. Veterinary Immunology and Immunopathology. 119(1-2). 131–136. 6 indexed citations
18.
Yamamoto, Toshiko, Todd Lasco, Kazuyuki Uchida, et al.. (2007). Mycobacterium bovis BCG vaccination modulates TNF-α production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs. Tuberculosis. 87(2). 155–165. 19 indexed citations
19.
Lasco, Todd, et al.. (2005). Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig. Tuberculosis. 85(4). 245–258. 45 indexed citations
20.
Saalmüller, Armin, Joan K. Lunney, Claudia Daubenberger, et al.. (2005). Summary of the animal homologue section of HLDA8. Cellular Immunology. 236(1-2). 51–58. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026